Physician profile
Akit Patel
NPI 1225268071
$1,139.76
in general payments reported to CMS, 2019-2025
15 companies · $438 in 2025
The $438 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $294 · 2023: $158 · 2024: $250 · 2025: $438.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $846.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $845.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $372.19 | 2019-2025 | |
| Medtronic, INC. | $145.97 | 2025 | Interstim |
| W. L. Gore & Associates, INC. | $120.10 | 2019 | |
| Genzyme Corporation | $103.79 | 2024-2025 | |
| Ardelyx, INC. | $70.66 | 2024-2025 | Ibsrela |
| Lilly USA, LLC | $64.81 | 2024-2025 | Omvoh |
| Ipsen Biopharmaceuticals, INC | $57.69 | 2024-2025 | Iqirvo |
| Regeneron Healthcare Solutions, INC. | $37.61 | 2025 | Dupixent |
| Pfizer INC. | $32.37 | 2025 | |
| Madrigal Pharmaceuticals | $27.71 | 2025 | Rezdiffra |
| Grifols USA, LLC | $27.61 | 2024 | Prolastin-C Liquid |
| Takeda Pharmaceuticals U.S.A., INC. | $25.19 | 2024 | Eohilia |
| Allergan, INC. | $22.51 | 2019 | |
| Braintree Laboratories, INC. | $17.12 | 2025 | Sutab, Suflave |
| Cook Medical LLC | $14.43 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Akit Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.